Los Angeles, March 18, 2016 -- Instavit, a pill-free approach to supplements, announces its complete product line will now be available at various online and retail locations throughout the U.S. Utilizing doctor formulations and advanced oral spray technology, the brand is carving out an entirely new niche in energy, sleep, and health supplements, one where bulky pill bottles and high calorie energy drinks are obsolete.
|
|||
“After a successful Canadian launch, we are happy to bring Instavit to the U.S. market,” said CEO of Instavit North America Tom Morse, who also co-founded 5-Hour Energy. “In an age and culture where our schedules are packed and we are always on the go, this product line makes it easy to keep up with your health, without falling behind in your day.”
Created by Dr. Jatin Joshi, a London-based surgeon diagnosed with Crohn’s disease, Instavit tackles several common setbacks associated with traditional pill supplements, such as lack of portability, purity, and convenience. The product line’s categories include Instant Energy, Sweet Dreams, Vitamin B12, Vitamin D, Daily Health, Immune Strength, and Clearer Thinking.
“Even after dealing with a nearly fatal health crisis, I still found it difficult to keep up with what should have been my daily supplement intake,” said Dr. Joshi. “Many supplements need to be taken multiple times throughout the day, and for myself, and many of my patients, I learned that carting around several pill bottles just wasn’t a reality. That is why I felt it was necessary to create a smarter solution to supplements. Instavit has been a massive health and lifestyle solution in my own life, and I am happy to have the opportunity to share that technology with individuals around the world.”
The pocket-sized Instavit products are made using the highest quality ingredients and contain no fillers or binders. To use, individuals simply spray the Instavit into their mouths and swallow.
Instavit will be available online at Amazon, Jet, and Lucky Vitamin, as well as trusted retailers around the country. For a complete list of Instavit’s availability and to learn more about the brand, please visit: www.instavit.com.
About Instavit
In treating his Crohn’s disease, Dr. J. Joshi sought a smarter and more reliable alternative to the traditional pill supplements he was taking. Leveraging the fast delivery, purity, and portability possible with oral spray technology, he formulated Instavit. In its effective delivery of micronutrients, Instavit puts an end to the bulky, bad tasting, and hard-to-swallow supplements of yesterday. Whether seeking a better night’s sleep or an instant energy boost, Instavit delivers it quickly, safely, and at a great price. Free from unnecessary fillers and binders, Instavit’s diverse product line is made in the USA using only the highest quality vitamins and minerals. Both made by doctors and used by doctors, Instavit introduces a fresh, effective, and medically backed approach to energy, sleep, and health supplements.
For more information, please visit www.instavit.com.
Travis Culver [email protected] 323.937.1951


Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 



